Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
about
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsCofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot studyThe macrophage: a therapeutic target in HIV-1 infectionHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesRedefining the viral reservoirs that prevent HIV-1 eradicationThe engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophagesBioinformatic analysis of HIV-1 entry and pathogenesis.Are T cells the only HIV-1 reservoir?Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent mannerFacilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTMutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infectionCritical role for the kinesin KIF3A in the HIV life cycle in primary human macrophagesThe Role of Caveolin 1 in HIV Infection and Pathogenesis.Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.Proteomic analysis of HIV-infected macrophagesThe role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma.HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Interactions between HIV-1 and mucosal cells in the female reproductive tractHost hindrance to HIV-1 replication in monocytes and macrophages.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageA Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophagesHIV/SIV infection primes monocytes and dendritic cells for apoptosis.Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytesAbsence of DICER in monocytes and its regulation by HIV-1.Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infectionPersistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytesDistribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapyGene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
P2860
Q24548940-925AE771-BAE8-4409-83BA-87864D5C9A81Q24645950-EC54765B-F2FF-43E2-9611-061EA5BF06A0Q26823236-C8854C5B-45D8-42AE-9DD3-470AA826E1B7Q26825087-5577E5E2-A37E-4E26-BB33-3B3BEA22C62FQ26827255-A38E1636-606F-485D-B97A-673AEC5D23F7Q27485769-93D19DE0-70ED-46E1-8395-C3A2756E8729Q27693321-C290AB6F-D46F-474E-BBA2-4C00222C2C1EQ28078850-C586F2F6-45C0-4A36-ACF8-81C0C41BB497Q28474468-67A1A908-4826-4F8F-8BF4-EC00312EB4DFQ28474651-47527AEC-8B92-4F06-87ED-58CDDC2F85F1Q28476094-BA5AB0CC-CB5F-473A-A86F-C87AE5BEB32BQ28476736-1820875E-CEAE-4547-9B9E-1240E0F6B5DBQ28910367-5651897E-1E19-435B-8F45-B470326E005FQ30527789-F4C23337-F6B8-43FF-A75E-F0227861B70CQ32183747-8F20AF37-F8EF-4644-B4A3-B15F21655815Q33346244-E39C9541-BFE9-4CF0-AFFD-99AF10A13ABBQ33513977-DBBDE69C-373E-45A5-835F-D327FF420F51Q33770687-5EAE5581-435D-410A-ACC2-E200763BFEC7Q33805288-636F8DE2-2E25-4E0A-A2E2-666E3DCEED14Q33805298-D2A2DB66-A988-4F19-BF55-527E65A4A1BEQ33815410-62DF2E4E-D5F5-4001-ABE2-B6EF460A64B9Q33846376-908AC475-10D6-4EAF-9CEC-D0CE244FD677Q33864438-E3935EFC-B448-412E-B4A9-0AB543EF8CA9Q33911247-3B36858D-6A80-4010-834B-E61E9E836A2CQ33919945-71264A80-9728-4D65-9367-7C256270B92BQ33921277-5D98F206-D540-4936-9798-D9004CB990A1Q33951949-9C527E0F-CD61-4FEC-A796-4F74DE1DD660Q34028490-B086A799-132F-44C5-ACDF-6F6704669AEBQ34097573-4656200A-C49A-4EF0-9AF9-650E803DF53BQ34127415-1AD83CF6-964D-4DF5-B861-89F5FD0351B7Q34186317-7C496C56-AB1A-4CAE-8C2F-354515A5EDD0Q34351941-94B054D1-CE4F-4449-9D81-D71BC5067AACQ34470969-4083B936-3AEE-4FAC-9FE9-11426DCD8328Q34588169-E741F7E8-BCB9-4386-8E9B-531AC818B1C3Q34590964-BEA0FAC1-B814-42A4-8794-5DE8FF14A388Q34649701-BC6E018B-4548-4D94-9C2D-D62DA69A6C23Q34727711-0212DDD1-632A-453C-BEE8-470420C83AA3Q34761139-FA972D16-1901-43B8-81FE-B086550BD20CQ34762506-A2C0F4B6-484D-4F26-AFC9-43929E4EC9D4Q34870353-D7C7DCB1-8DFA-4F1C-9419-FD669B2E4E46
P2860
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14
@nl
Evidence for human immunodefic ...... active antiretroviral therapy.
@en
type
label
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14
@nl
Evidence for human immunodefic ...... active antiretroviral therapy.
@en
prefLabel
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14
@nl
Evidence for human immunodefic ...... active antiretroviral therapy.
@en
P2093
P2860
P1433
P1476
Evidence for human immunodefic ...... active antiretroviral therapy.
@en
P2093
David Muthui
David Nickle
James I Mullins
Sarah Holte
Scott Brodie
Yon Hwangbo
P2860
P304
P356
10.1128/JVI.76.2.707-716.2002
P407
P577
2002-01-01T00:00:00Z